Novozymes A/S (NVZMY) Q3 2025 Earnings Call Transcript
Source: SeekingAlpha
2025-11-06 06:36:09 ET
Novozymes A/S (NVZMY) Q3 2025 Earnings Call November 6, 2025 3:00 AM EST
Company Participants
Tobias Björklund - Head of Investor Relations
Ester Baiget - President & CEO
Rainer Lehmann - Executive VP & CFO
Claus Fuglsang - Chief Scientific Officer
Tina Fanø - Executive Vice President of Planetary Health Biosolutions
Andrew Taylor
Henrik Nielsen - EVP of Human Health Biosolutions and Strategy & Integration
...
Read the full article on Seeking Alpha
For further details see:
Novozymes A/S (NVZMY) Q3 2025 Earnings Call Transcript
Novonesis AS - Class B
NASDAQ: NVZMF
NVZMF Trading
-0.07% G/L:
$56.10 Last:
1,000 Volume:
$56.10 Open:
NVZMF Latest News
November 06, 2025 05:12:02 am
Novonesis delivered 8% organic sales growth in the first nine months of 2025
